AbCellera Biologics Inc. (ABCL) Social Stream



AbCellera Biologics Inc. (ABCL): $12.71

-0.47 (-3.57%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ABCL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 381

in industry

ABCELLERA BIOLOGICS INC (ABCL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ABCL.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 4 $55 $25 $45.25 $13.52 234.69%
2021-12-05 5 $53 $25 $40.8 $13.52 201.78%
2021-12-19 7 $53 $25 $39.833 $13.52 194.62%
2021-12-21 7 $53 $25 $38 $13.52 181.07%
2022-02-11 5 $45 $25 $33 $13.52 144.08%
2022-02-25 5 $40 $20 $30 $13.52 121.89%
2022-05-09 5 $40 $20 $29.6 $13.52 118.93%
2022-05-11 5 $32 $14 $24.8 $13.52 83.43%
2022-08-09 5 $32 $14 $23.6 $13.52 74.56%
2022-08-11 5 $34 $14 $24 $13.52 77.51%
2022-10-23 5 $34 $13 $23.8 $13.52 76.04%
2022-11-02 4 $34 $13 $23.6 $13.52 74.56%
2022-11-09 5 $32 $20 $23.6 $13.52 74.56%
2022-11-16 6 $32 $20 $24.5 $13.52 81.21%

The Trend in the Analyst Price Target


ABCL's average price target has moved down $20.9 over the prior 15 months.

Over the past 49 weeks, ABCL's average upside potential has been 180.06%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-02-11 5 45 25 33.0 9.64 242.32%
2022-02-25 5 40 20 30.0 8.93 235.95%
2022-02-28 5 40 20 29.6 8.71 239.84%
2022-10-23 5 34 13 23.8 10.31 130.84%
2022-11-09 5 32 20 23.6 11.81 99.83%

ABCL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 6 0 0 0 0 6

The Trend in the Broker Recommendations


Over the past 31 weeks, ABCL's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ABCELLERA BIOLOGICS INC's variance in analysts' estimates is lower than -1455.25% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, ABCELLERA BIOLOGICS INC's number of analysts covering the stock is greater than 149.01% of them.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, ABCELLERA BIOLOGICS INC's upside potential (average analyst target price relative to current price) is higher than 1773.94% of them.
  • In terms of how ABCELLERA BIOLOGICS INC fares relative to stocks in the large market cap category, note that its average analyst price target is higher than 340.24% of that group.

In the Pharmaceutical Products industry, CGC, TLRY, and BLUE are the three stocks most similar to ABCELLERA BIOLOGICS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for ABCL? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5901 seconds.